Mivacurium
From Wikipedia, the free encyclopedia
 |
|
|
Mivacurium
|
|
| Systematic (IUPAC) name | |
| bis[3-[6,7-dimethoxy-2-methyl-1- [(3,4,5-trimethoxyphenyl)methyl]- 3,4-dihydro- 1H-isoquinolin-2-yl] propyl] oct-4-enedioate | |
| Identifiers | |
| CAS number | 106791-40-6 |
| ATC code | M03AC10 |
| PubChem | 71316 |
| DrugBank | APRD01119 |
| Chemical data | |
| Formula | C58H80N2O14+2 |
| Mol. weight | 1029.26 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Mivacurium is a short-acting bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant used to facilitate intubation and relax skeletal muscles as an adjunct to general anesthesia. Mivacurium has recently been discontinued by Abbott Pharmaceuticals because of the timeframe for manufacture and the competitive environment. Alternatives vary in onset time and duration of action.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Muscle relaxants (M03) edit | ||
|---|---|---|
| Peripherally acting: |
Alcuronium, Atracurium, Cisatracurium, Dimethyltubocurarine, Doxacurium chloride, Fazadinium bromide, Gallamine, Hexafluronium, Mivacurium chloride, Pancuronium, Pipecuronium bromide, Rocuronium bromide, Suxamethonium, Tubocurarine, Vecuronium |
|
| Centrally acting: |
Baclofen, Carisoprodol, Chlormezanone, Chlorzoxazone, Cyclobenzaprine, Febarbamate, Mephenesin, Methocarbamol, Orphenadrine, Phenprobamate, Phenyramidol, Pridinol, Styramate, Tetrazepam, Thiocolchicoside, Tizanidine, Tolperisone |
|
| Directly acting: | ||
